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Maximal oxygen uptake (VO2max) has been used to assess risk for all-cause mortality and cardiovascular disease
(CVD), and low VO2max has recently been associated with increased mortality from breast cancer. The purpose of
this study was to determine the proportion of breast cancer survivors with 2 or more risk factors for CVD
exhibiting a low VO2max and to determine whether sub-maximal endpoints which could be applied more readily
to intervention research would correlate with the maximal treadmill test. We performed a single VO2max test on a
treadmill with 30 breast cancer survivors age 30–60 (mean age 50.5 ± 5.6 years) who had 2 or more cardiac risk
factors for CVD not related to treatment and who had received systemic therapy and or left chest radiation.
Submaximal VO2 endpoints were assessed during the VO2max treadmill test and on an Arc trainer. Resting left
ventricular ejection fraction (LVEF) was also assessed by echocardiogram (ECHO) or multi-gated acquisition scan
(MUGA). A majority (23/30) of women had a VO2max below the 20th percentile based on their predicted normal
values. The group mean resting LVEF was 60.5 ± 5.0%. Submaximal VO2 measures were strongly correlated with
the maximal test including; 1) 85% age predicted maximum heart rate VO2 on treadmill, (r = .89; p < 0.001), 2)
treadmill VO2 at anaerobic threshold (AT), (r = .83; p < 0.001), and 3) Arc VO2 at AT, (r = .80; p < 0.001). Breast
cancer survivors with 2 or more CVD risk factors but normal LVEF had a low cardiorespiratory fitness level
compared to normative values in the healthy population placing them at increased risk for breast cancer and
cardiovascular mortality. Submaximal VO2 exercise testing endpoints showed a strong correlation with the
VO2max test in breast cancer survivors and is a good candidate for testing interventions to improve
cardiorespiratory fitness.
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Exercise testingIntroduction
More than 290,000 women were estimated to be
diagnosed with breast cancer in 2012, and the number
of survivors has risen beyond 2.5 million (ACS 2012).
There is an excess of cardiovascular deaths in breast
cancer survivors (Eloranta et al. 2012). Likely due to
physical inactivity and weight gain as well as side effects
of treatment (Ewer et al. 2011; Jones et al. 2007a). Low
cardiorespiratory fitness usually measured by oxygen up-
take at maximal or peak exercise (VO2 max or peak) is
inversely correlated with cardiovascular and all cause
mortality, and breast cancer deaths (Blair et al. 1996;
Blair et al. 1989; Peel et al. 2009). Women with low* Correspondence: dburnett@kumc.edu
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in any medium, provided the original work is pcardiorespiratory fitness (below VO2max of 8 METS
(28 mL.kg-1.min-1 VO2 or below) had a nearly 3 fold in-
crease in breast cancer deaths compared to those who
reached a level above 8 METS (Peel et al. 2009). A re-
cent study indicated breast cancer survivors had a 22%
lower VO2max compared to their age matched healthy,
sedentary non-cancer peers (Jones et al. 2012).
While a maximal exercise test is the gold standard for
assessing cardiorespiratory fitness, a maximal cardiorespiratory
exercise test requires participants to push themselves to
volitional exhaustion and peak heart rate (HR) (ACSM
2009). In contrast, submaximal testing allows for a
measure of sustainable cardiorespiratory exercise cap-
acity (Wasserman et al. 1999), without maximizing
heart rate. In addition, submaximal exercise testing isan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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require physician presence during the test.
Submaximal exercise testing has been used to provide
a measure of cardiorespiratory fitness, with outcomes
based on anaerobic threshold in patients with a history
of congestive heart failure (Kemps et al. 2008), stroke
(Eng et al. 2004), cancer (Carlson et al. 2006), and ath-
letic populations (Bernardi et al. 2010). Furthermore,
submaximal testing is more feasible for use in de-
conditioned women who may discontinue a maximal
test early because of fatigue - a complaint in 50-80% of
breast cancer survivors who have undergone systemic
therapy (Andrykowski et al. 1998; Gitt et al. 2002).
A recent meta-analysis indicates a need for a
standardized and objective measure of fitness which can
be readily utilized in the breast cancer survivorship
population (McNeely et al. 2006). Accordingly, we
investigated the association between the gold standard
measure of cardiorespiratory fitness (VO2max) with dif-
ferent submaximal testing endpoints in breast cancer
survivors. We hypothesized the VO2 at submaximal
endpoints would be highly correlated with VO2max in
breast cancer survivors and they would have a lower
VO2max than age and gender matched normative values.
Important clinical implications can arise from evaluating
cardiorespiratory fitness in breast cancer survivors and
targeting those in the greatest need of preventive measures.
Materials and methods
Study participants
This was a cross-sectional study using a within-subject
design to investigate the cardiorespiratory fitness
and associations between submaximal and maximal
cardiorespiratory tests in breast cancer survivors. A total
of 30 breast cancer survivors were enrolled in the study.
Recruitment was performed by the Breast Cancer Sur-
vivorship Navigator/Coordinator from long-term sur-
vivorship clinics at the University of Kansas Breast
Cancer Survivorship Center (BCSC). Inclusion criteria
were as follows: previously diagnosed with stage I-IIIa
breast cancer; ages 30–60; no evidence of metastatic dis-
ease; at least 3-months from completing initial chemo-
therapy and/or radiation therapy; and within 10 years of
initial diagnosis. Subjects had to also have 2 of the
following cardiac risk factors: body mass index (BMI) ≥
25 kg.m-2, hypertension (systolic blood pressure ≥
140 mm Hg and/or diastolic blood pressure ≥ 90 mm
Hg),(ACSM 2009) elevated low density lipoprotein
(LDL) (fasting serum level ≥ 130 mg.dL-1) (NCEP 2002),
positive family history of myocardial infarction, coronary
revascularization, or sudden death in mother, father, or
first-degree relative, sedentary lifestyle (not currently
participating in habitual exercise of moderate to vigor-
ous intensity for two or fewer sessions per week),smoker (currently smoking or quit smoking within the
last six months); and 1 treatment-related risk factor:
chemotherapy +/− left breast radiation; and available
results of a resting ECHO or MUGA prior to receiving
initial chemotherapy. Objectives were to analyze VO2max
and submaximal endpoints in breast cancer survivors
who had been treated with adjuvant therapy. The
submaximal tests utilized a treadmill and an Arc Trainer
(Cybex Arc Trainer 750AT). An arc Trainer was used in-
stead of a treadmill in cases where minimization of verti-
cal stress was needed such as women with knee and
back problems. Arc Trainers use a low-impact mechan-
ical design with production of lower vertical forces and
joint loading compared to walking on a treadmill (Lu
et al. 2007; Turner et al. 2010).
The study was approved by the University of Kansas
Medical Center Human Subjects Committee (HSC
#12251) and written informed consent was obtained
from all participants at an orientation meeting prior to
conducting any study testing or activities.
Outcomes
All study procedures were conducted during three testing
sessions within a two week time frame at the Clinical
Translational Science Unit (CTSU) on the University of
Kansas Medical Center campus and the cardiovascular lab
located at the University of Kansas Hospital. Participants
were instructed to refrain from exercise 48 hours prior to
maximal and submaximal cardiorespiratory testing. In
addition, all participants were asked not to consume any
food, caffeine, alcohol, and tobacco products three hours
prior to exercise tests. The exercise testing sessions were
between 2 and 14 days apart and at the same time of the
day. All cardiorespiratory tests followed the American
College of Sports Medicine (ACSM) guidelines for
procedures during graded exercise testing (ACSM 2009).
In addition, the exercise testing sessions were at least 48 -
hours, but no more than 14 days, from the resting ECHO/
MUGA. Data on demographic information and health his-
tory were obtained (Table 1).
Maximal treadmill test
Cardiorespiratory fitness was assessed using a modified
Balke protocol (Balke 1959; Blair et al. 1989). Tests were
conducted by qualified personnel including an exercise
physiologist, nurse, and CTSU medical monitor. An
integrated metabolic measurement system (Parvo
Medics TrueOne 2400) was used for measurement of
maximal oxygen consumption interfaced with an ECG
system (Schiller AT-10 Cardiograph). The metabolic cart
was set to produce a 15-second average of the data
collected during gas analyses for all tests. Equipment
was calibrated per manufacturers recommendation prior
to testing. Participants were fitted and acclimated to a
Table 1 Non-treatment related characteristics
Variable Breast cancer survivors (n = 30)
Age (y) 50.5 ± 5.6
Time since diagnosis (months) 58 ± 27
BMI (kg.m-2) 29.2 ± 5.3
Body fat (%) 44.5 ± 7.7
Overweight (BMI > 25 kg.m-2) 25/30 (83%)
Hypertension 8/30 (27%)
↑ LDL 20/30 (66%)
Family history heart disease 12/30 (40%)
Sedentary lifestyle 10/30 (33%)
Smoker 1/30 (3%)
Note: BMI, body mass index; LDL, low density lipoprotein.
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before stepping on to the treadmill. Participants were
encouraged to give a maximal effort during the test. The
protocol involved a slow progression towards a static
speed of 3.3 MPH at the start of minute three, with an
initial minute at 2.0 MPH and a second minute at 2.7
MPH. At minute three the speed increased to 3.3 MPH
and a grade of 1%. The grade increased 1% each minute
thereafter. Participants continued walking on the tread-
mill at increasing incline until exhaustion, unless
indications for terminating the maximal test were
observed (ACSM 2009). Participants cooled-down at
1.5-2.0 MPH and a level grade for a period of two to five
minutes. Expired air was analyzed for O2 and CO2.
Heart rate, blood pressure, and rating of perceived exer-
tion score were determined at the end of each two mi-
nute stage. Confirmation of a maximal effort was
determined by meeting three out of four of the following
criteria; 1) plateau in heart rate and oxygen uptake with
increased workload, 2) respiratory exchange ratio > 1.1,
3) rating of perceived exertion > 17, and 4) heart rate >
90% of age predicted maximal heart rate.
Submaximal treadmill test
Cardiorespiratory fitness submaximal endpoints on the
treadmill were determined by the VO2 at anaerobic
threshold and 85% age predicted maximum heart rate. Ini-
tial criteria for anaerobic threshold was established by
using the respiratory exchange ratio ≥ 1.0. Participants
were allowed to continue for three consecutive 15 second
averages at a respiratory exchange ratio ≥ 1.0 to ensure an-
aerobic threshold was reached. Post-test confirmation of
the anaerobic threshold was made upon visual assessment
of 1) V-slope method, and 2) ventilatory equivalent tech-
nique to rule out hyperventilation. Submaximal VO2 at
85% age predicted maximum heart rate was assessed with
the calculation [(220-age) × 0.85] and determination ofthe corresponding VO2 at that heart rate during maximal
testing on the treadmill.
Submaximal arc (Cybex 750AT) test
After a brief familiarization trial followed by a short rest
period, participants began the Arc submaximal test.
Participants’ weight was input into the console before
starting the test. The manual mode was used for testing,
with initial workload set at a resistance level of 15.
Participants were asked to maintain between 80–100
strides per minute and a level grade was used through-
out the test. Workload was adjusted to allow a steady in-
crease in heart rate until subjects reached the anaerobic
threshold endpoint. Increased workload was performed
manually by a gradual increase in wattage while
adjusting resistance in two minute stages. Resistance at
each two minute stage varied between participants to
allow a steady increase in heart rate, and was adjusted
by a 5–10 numerical increase on the Arc trainer console
resistance key pad. The cardiorespiratory fitness
submaximal endpoint on the Arc trainer was determined
by the VO2 at anaerobic threshold. Criteria for anaerobic
threshold was determined by the same method as the
submaximal treadmill endpoint.
Cardiorespiratory fitness (VO2max)
Cardiorespiratory fitness was measured by the
participants’ VO2max during the maximal treadmill test.
Group mean VO2max was compared to the normative
VO2max value for healthy age-matched women (ACSM
2009). We performed our maximal treadmill test with a
similar Balke protocol that was used for determining
normative VO2max values.
Left ventricular ejection fraction
Resting LVEF was performed on all breast cancer
survivors by either an ECHO or MUGA, depending on
which cardiac function test the participant had prior to
starting breast cancer treatment. As previously
mentioned, all breast cancer survivor participants had an
ECHO or MUGA test within 2 weeks of their
cardiorespiratory test. Cardiac function (LVEF) was
assessed by a cardiologist not associated with the study.
Anthropometrics and body composition
Body weight was assessed to the nearest 0.1 kg, using an
electronic scale (Health o meter, Boca Raton, Fl). A
stadiometer was used to measure height without shoes
to the nearest 0.1 cm (SECA). Body composition was
measured by dual-energy x-ray absorptiometry in the
total body scanning mode with a Lunar Prodigy DXA
machine (Lunar Corp., Madison, WI). Body mass index
was calculated as the weight in kilograms divided by the
height in meters squared (kg.m-2).
Table 3 Cardiorespiratory outcomes
Variable Breast cancer survivors
(n = 30)
Maximal VO2 (mL
.kg-1.min-1) 25.4 ± 5.3
Maximal HR (bpm) 169 ± 12
VO2 at AT on treadmill (mL
.kg-1.min-1) 20.5 ± 4.3
VO2 at AT on Arc (mL
.kg-1.min-1) 19.0 ± 4.4
VO2 at 85% APMHR (mL
.kg-1.min-1) 19.9 ± 3.0
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Blood pressure and resting heart rate was measured at
rest prior to exercise testing. Family history of heart dis-
ease, sedentary lifestyle, and smoking habits was assessed
from the chart review, clinical interview, and self-report
during initial screening for the study.
Statistical analysis
Pre-formatted data collection and case report forms
were used for both clinical and laboratory data. Study
data was entered into an Excel database by a trained
data clerk not related to the study. Values and
percentages were used to describe VO2max in breast can-
cer survivors compared to age and gender matched nor-
mative values. Distribution normality and was verified
using the Shapiro-Wilk test and variance homogeniety
was confirmed from a Levene’s test. After assumptions
were met, an association between all submaximal VO2
endpoints and VO2max was examined using Pearson cor-
relation coefficients. Correlations were categorized as
0.26 to 0.49 is a low correlation, 0.50 to 0.69 is moder-
ate, 0.70 to 0.89 is high, and 0.90 to 1.00 is very high as
described by Munro et al. (Munro 1993). All analyses
were two-tailed with alpha = 0.05, and performed




Cohort characteristics and non-treatment CVD risk
factors are listed in Table 1. Mean age was 50.5 ± 5.6 -
years, 29/30 were caucasion, 1/30 was Latino, and the
group had an average elapsed time since diagnosis of 58 -
months. The most frequent non-treatment related risk
factors were BMI > 25 kg/m2 (83%), elevated LDL (66%),
family history of heart disease (40%), and sedentary life-
style (33%). Additionally, the group mean body fat % was
44.5 ± 7.7%. Treatment related risk factors are listed in
Table 2. 28/30 (93%) of the breast cancer survivors were
postmenopausal at time of study, while 20/30 (66%) of
the women were treated with an aromatase inhibitor. ATable 2 Treatment related characteristics
Variable Breast cancer survivors (n = 30)
Current Aromatase Inhibitor 14/30 (47%)
Current Tamoxifen 1/30 (3%)
Past Aromatase Inhibitors 4/30 (13%)




Left chest radiation 12/30 (40%)large majority (80%) of the women received either doxo-
rubicin or epirubicin, 27% were treated with trastuzamab,
and 40% had left chest radiation. Also, the group mean
LVEF at time of study was 60.5 ± 5%, which was signifi-
cantly decreased (p = 0.02) from 63.2 ± 5.7% at time of
diagnosis and prior to treatment.
Cardiorespiratory fitness levels
All cardiorespiratory fitness measures are listed in
Table 3. 23/30 (77%) of the breast cancer survivors with
2 or more CVD risk factors tested below the 20th per-
centile consistent with low cardiorespiratory fitness
based on their age group and gender for VO2max as
established by the American College of Sports Medicine
(ACSM 2009), despite a mean time since diagnosis of
over 4 years and a normal group mean LVEF at time of
study. All submaximal testing of VO2 endpoints showed
a high correlation to the actual measured VO2max when
comparing within subject results (Figure 1), and the VO2
at 85% age predicted maximum heart rate on the tread-
mill showed the highest correlation with VO2max. Our
analysis of cardiorespiratory fitness revealed that the
breast cancer survivor group’s mean VO2max (25.4 ±
5.3 mL.kg-1.min-1) was similar to the 20th percentile
threshold value (25.1 mL.kg-1.min-1) for age and gender
group matched normative values.
Adverse events from testing
All 30 maximal and 30 submaximal cardiorespiratory
tests were completed without any adverse events. During
maximal testing twenty-eight of thirty participants metHR at AT on treadmill (bpm) 148 ± 13
HR at AT on Arc (bpm) 144 ± 13
HR at 85% APMHR (bpm) 144 ± 5
Predicted Maximal HR (bpm) 170 ± 6
Predicted VO2- 85% APMHR (mL
.kg-1.min-1) 24.5 ± 7.2
Predicted VO2max (mL
.kg-1.min-1) 34.5 ± 8.8
Resting HR (bpm) 78 ± 10
Maximal O2 pulse (mL/beat) 11.5 ± 1.5
Pre-Treatment LVEF 63.2 ± 5.7%
Study LVEF 60.5 ± 5.0%
Note: HR, heart rate; AT, anaerobic threshold; APMHR, age predicted maximal





















r= 0.83, p= <0.001
BA
r= 0.80, p= <0.001
C
r= 0.89, p= <0.001
Submaximal VO2 (mL.kg-1.min-1)
Figure 1 The association between (A) treadmill 85% age predicted maximum heart rate endpoint, (B) treadmill AT endpoint, and
(C) Arc trainer AT endpoint submaximal tests with maximal oxygen uptake.
Burnett et al. SpringerPlus 2013, 2:68 Page 5 of 7
http://www.springerplus.com/content/2/1/68our established criteria for a maximal effort as explained
previously. Two of the participants discontinued the test
secondary to a claustrophobic sensation related to the
mouthpiece, fatigue, and/or shortness of breath.
Symptoms were resolved by discontinuing the test and
having the participants rest while monitoring all post-
test vitals. Even though two participants discontinued
the maximal test prior to reaching maximal criteria, both
participants achieved > 85% APMRH on the treadmill
and have been included in the analyses.
Discussion
In our breast cancer survivors cohort, all participants
had ≥ 2 risk factors for CVD not related to treatment
and 77% of this group had low cardiorespiratory fitness
measured by VO2max despite a normal LVEF at time of
study. These results suggest that they are at a higher risk
of breast cancer and cardiovasular mortality (Blair et al.
1996; Blair et al. 1995; Peel et al. 2009). Our results are
similar to three earlier reports in breast cancer survivors,
(one of which women had controlled hypertension),
suggesting the majority of women with non-treatment
related CVD risk factors have a lower VO2max compared
to healthy women even with a concomitant normal
LVEF (Jones et al. 2012; Jones et al. 2007b; Tolentino
et al. 2010). Our study differs from the earlier studies
since we used a similar VO2max protocol (Balke proto-
col) to the standardized treadmill test used for determin-
ing normative values (ACSM 2009) and we reported
pre- and post-treatment LVEF.
Collectively, the double impact from the effects of life-
style changes and breast cancer adjuvant treatment may
increase the risk for late-onset CVD. Despite this know-
ledge, there is not a current stratification tool to accur-
ately assess increased risk of CVD morbidity and
mortality in breast cancer survivors. For example, sub-
clinical cardiac dysfunction may go unnoticed until more
overt symptoms occur and still remain undetected by a
resting echocardiogram (ECHO) (Cardinale et al. 2004;Civelli et al. 2006). However, exercise tests may be more
sensitive than resting tests in identifying cardiac dys-
function in long-term survivors (Gottdiener et al. 1981;
Klewer et al. 1992; Weesner et al. 1991). Therefore, exer-
cise testing may serve as an important clinical tool for
identifying breast cancer survivors who are asymptom-
atic, but at increased risk for the development of CVD.
Furthermore, cardiorespiratory exercise testing can pro-
vide an objective evaluation of cardiorespiratory fitness,
reducing the variability found in self-reported activity
measures by 70-80% (Blair & Church 2004).
Sub-maximal exercise testing with VO2 measured at
the anaerobic threshold has shown good correlation with
maximal exercise testing in individuals where a max-
imum test would be difficult because of disability or de-
conditioning including those with congestive heart fail-
ure, stroke, or undergoing bone marrow transplant
(Carlson et al. 2006; Eng et al. 2004; Kemps et al. 2008).
To our knowledge, this is the first study to investigate
the association between maximal and submaximal
cardiorespiratory fitness testing in breast cancer
survivors. We found that submaximal VO2 endpoints
were highly correlated with VO2max, indicating that
submaximal testing can be a good measure of
cardiorespiratory fitness in breast cancer survivors. Our
study produced similar results when comparing
submaximal VO2 at anaerobic threshold and 85% age
predicted maximum heart rate to VO2max, suggesting
that submaximal testing can be used as a surrogate for
VO2max testing in breast cancer survivors.
The submaximal VO2 at 85% age predicted maximum
heart rate was used because this predetermined endpoint
can be performed without expensive gas analysis equip-
ment and can be more feasible than measuring anaer-
obic threshold when a large number of patients or
subjects need to be tested. Submaximal VO2 endpoint at
85% age predicted maximum heart rate had a similar
group mean heart rate and VO2 compared to the anaer-
obic threshold endpoint. This is important to note since
Burnett et al. SpringerPlus 2013, 2:68 Page 6 of 7
http://www.springerplus.com/content/2/1/68anaerobic threshold is a helpful indicator for determin-
ing fitness level and for measuring the effect of exercise
training (Casaburi 1994; Casaburi et al. 1991). Overall,
the submaximal VO2 endpoint at 85% age predicted
maximum heart rate showed the highest correlation to
actual measured VO2max, as seen in Figure 1. Our
findings suggest using the speed and grade at the 85%
age predicted maximum heart rate endpoint during a
submaximal test for predicting VO2 and objectively
measuring cardiorespiratory fitness for breast cancer
survivors, especially when repeated measures are
required for assessing improvement after an exercise
intervention. Our results support the use of a
submaximal cardiorespiratory test as an objective meas-
ure of fitness that can be used for breast cancer
survivors. Furthermore, this study suggests that a
submaximal cardiorespiratory test using a modified
Balke protocol with an endpoint set at 85% age predicted
maximum heart rate can be performed when the equip-
ment and personnel needed to conduct directly
measured oxygen uptake via indirect calorimetry are not
available. A validation study to design an accurate pre-
dictive model for extrapolating VO2max from a
submaximal testing end point at the 85% age predicted
maximum heart rate endpoint.
We are unaware of previous studies that have used an
Arc trainer with decreased load bearing force as an exer-
cise testing modality to examine cardiorespiratory fitness
in breast cancer survivors, many of whom have age-
related or aromatase inhibitor induced arthalgia and
may prefer alternate forms of testing. Turner et al.
showed that VO2max and time to attain VO2max were
similar when comparing results between testing modal-
ities including an Arc trainer and a treadmill in healthy
adults (Turner et al. 2010). During our study three
participants were unable to complete testing on the Arc
trainer due to their inability to coordinate the movement
between the lower and upper limbs simultaneously. Also,
the Arc trainer produced significantly lower VO2 and
heart rate at anaerobic threshold versus the treadmill
submaximal test (Table 3). Overall, we suggest that the
benefit of using an Arc trainer does not outweigh diffi-
culty with performing the required coordinated
movements and lack of standard testing protocol. Also,
It is important to note that there were no breast cancer
survivors in our study that could not complete testing
on the treadmill due to joint or muscle pain.
This is the first study to investigate the association be-
tween the gold standard for cardiorespiratory fitness
(VO2max) to submaximal VO2 tests in breast cancer
survivors who had been treated with adjuvant therapy.
The findings from this study indicate that breast cancer
survivors with ≥ 2 CVD risk factors had low
cardiorespiratory fitness and submaximal testing on thetreadmill is a feasible, objective measure of fitness that
can be used in breast cancer survivors. Limitations of
this study include the small sample size (n = 30), lack of
racial diversity, and lack of non-cancer controls.
Future research should focus on using a high-risk
breast cancer control group with ≥ 2 CVD risk factors to
compare maximal and sub-maximal VO2 measures. In
addition, novel approaches should be made to improve
cardiorespiratory fitness during sustainable exercise
interventions for breast cancer survivors.
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